Invention Grant
US07972817B2 Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
有权
能够使用从血浆或血清提取的细胞外RNA检测，监测或评估癌症的方法
- Patent Title: Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
- Patent Title (中): 能够使用从血浆或血清提取的细胞外RNA检测，监测或评估癌症的方法
-
Application No.: US11216858Application Date: 2005-08-31
-
Publication No.: US07972817B2Publication Date: 2011-07-05
- Inventor: Michael Kopreski
- Applicant: Michael Kopreski
- Applicant Address: US NJ Long Valley
- Assignee: OncoMedx, Inc.
- Current Assignee: OncoMedx, Inc.
- Current Assignee Address: US NJ Long Valley
- Agency: McDonnell Boehnen Hulbert & Berghoff
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12P19/34 ; C07H21/02 ; C07H21/04 ; C07H21/00
Abstract:
This invention relates to the use of extracellular ribonucleic acid (RNA) found circulating in the plasma or serum fraction of blood. Specifically, this invention enables the extraction of circulating RNA from plasma or serum and utilizes nucleic acid amplification assays for the identification, detection, inference, monitoring, or evaluation of any such RNA. Further, this invention allows the qualitative or quantitative detection of extracellular RNA circulating in the plasma or serum of humans.
Public/Granted literature
Information query
